2012•Practical Journal of Clinical MedicineRequires access

Clinical significance of HER-2 protein expression in Human Gastric Carcinoma

Liu Du-li

Open publisher page 0 citations

Abstract

Objective To investigate the correlation between HER-2 protein expression and clinicopathological factors of gastric carcinoma.Methods HER-2 protein expression was detected by immunohistochemistry(Envision) in 70 gastric carcinoma specimens,and the corresponding clinical and pathological characteristics were also analyzed.Results The positive rate of HER-2 protein expression was 27.1%(19/70).HER-2 over-expression rate was 15.7%(11/70).HER-2 protein expression was associated with the tumor differentiation,invasion depth,lymph note metastasis and TNM stage(P 0.05),but not with sex,age,tumor site and tumor size(P 0.05).Conclusion HER-2 expression may participate in the development,invasion and metastasis of gastric carcinoma.Detecting the HER-2 status is a prerequisite of? trastuzumab monoclonal antibody(Herceptin) therapy for gastric carcinoma,and can assess the malignant biological behaviors and prognosis of gastric carcinoma.

About this research paper

What this paper is about

Objective To investigate the correlation between HER-2 protein expression and clinicopathological factors of gastric carcinoma.Methods HER-2 protein expression was detected by immunohistochemistry(Envision) in 70 gastric carcinoma specimens,and the corresponding clinical and pathological characteristics were also analyzed.Results The positive rate of HER-2 protein expression was 27.1%(19/70).HER-2 over-expression rate was 15.7%(11/70).HER-2 protein expression was associated with the tumor differentiation,invasion depth,lymph note metastasis and TNM stage(P 0.05),but not with sex,age,tumor site and tumor size(P 0.05).Conclusion HER-2 expression may participate in the development,invasion and metastasis of gastric carcinoma.Detecting the HER-2 status is a prerequisite of? trastuzumab monoclonal antibody(Herceptin) therapy for gastric carcinoma,and can assess the malignant biological behaviors and prognosis of gastric carcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the correlation between HER-2 protein expression and clinicopathological factors of gastric carcinoma.Methods HER-2 protein expression was detected by immunohistochemistry(Envision) in 70 gastric carcinoma specimens,and the corresponding clinical and pathological characteristics were also analyzed.Results The positive rate of HER-2 protein expression was 27.1%(19/70).HER-2 over-expression rate was 15.7%(11/70).HER-2 protein expression was associated with the tumor differentiation,invasion depth,lymph note metastasis and TNM stage(P 0.05),but not with sex,age,tumor site and tumor size(P 0.05).Conclusion HER-2 expression may participate in the development,invasion and metastasis of gastric carcinoma.Detecting the HER-2 status is a prerequisite of? trastuzumab monoclonal antibody(Herceptin) therapy for gastric carcinoma,and can assess the malignant biological behaviors and prognosis of gastric carcinoma.

Key concepts: Medicine, Immunohistochemistry, Gastric carcinoma, Trastuzumab, Pathological, Stage (stratigraphy), Metastasis, Monoclonal antibody

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical significance of HER-2 protein expression in Human Gastric Carcinoma — Research Paper | ScholarLens